Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options.
Does Aquaporin-4-Seronegative Neuromyelitis Optica Exist?
Embelin Suppresses Dendritic Cell Functions and Limits Autoimmune Encephalomyelitis Through the TGF-β/β-catenin and STAT3 Signaling Pathways.
MRI of the cervical nerve roots in the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy: a single-institution, retrospective case-control study.
Rotating-polarization CARS microscopy: combining chemical and molecular orientation sensitivity.
In vivo histology of the myelin g-ratio with magnetic resonance imaging.
Identity-by-Descent Mapping to Detect Rare Variants Conferring Susceptibility to Multiple Sclerosis.
Clinical outcomes in multiple sclerosis patients following venous angioplasty.
Gait variability and multiple sclerosis.
cFLIP is critical for oligodendrocyte protection from inflammation.
Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.
Acute bilateral visual loss in a young adult.
Pragmatic exercise intervention in people with mild to moderate multiple sclerosis: A randomised controlled feasibility study.
Role of a novel HLA-DQA1*01:02;DRB1*15:01 mixed-isotype heterodimer in the pathogenesis of 'humanized' multiple sclerosis-like disease.
Soluble CD146 in cerebrospinal fluid of active multiple sclerosis.
Does lesioning surgery have a role in the management of multietiological tremor in the era of Deep Brain Stimulation?
Education attenuates the negative impact of traumatic brain injury on cognitive status.
S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures.
Galanin is an autocrine myelin and oligodendrocyte trophic signal induced by leukemia inhibitory factor.
Multiple sclerosis drugs: how much bang for the buck?
The Immune Pathogenesis of Multiple Sclerosis.
Duloxetine for the Treatment of Overactive Bladder Syndrome in Multiple Sclerosis: A Pilot Study.
Study of curcumin immunomodulatory effects on reactive astrocyte cell function.
Optimizing therapy early in multiple sclerosis: An evidence-based view.
The use of interferon Beta and glatiramer acetate in multiple sclerosis.

Pages